Moreover, expression changes of epithelial and mesenchymal markers were also confirmed by western blotting and immunohistochemistry analysis performed with subcutaneous tumor tissues derived from nude mice (Supplementary Fig. 4B and C), suggesting that RBBP6 enhances EMT in vivo. This evidence concerns the gene RBBP6 and neoplasm.